<DOC>
	<DOCNO>NCT02031289</DOCNO>
	<brief_summary>We perform prospective randomize trial 1'000 patient undergoing cardiac surgery . The study answer question whether preoperative treatment anemia iron deficiency indeed improve transfusion need ( primary outcome ) important clinical outcome ( secondary outcome ) large group cardiac surgical patient . The list inclusion exclusion criterion deliberately choose short patient group largely reflect today 's clinical practice . - Trial medical product</brief_summary>
	<brief_title>Impact Preoperative Treatment Anemia Iron Deficiency Cardiac Surgery Outcome .</brief_title>
	<detailed_description>Anemic iron deficiency patient randomize treatment placebo group . Treatment ( see ) give day operation ( day -1 ) maximum 2 day prior operation ( day -2 ) iron deficiency patient maximum 3 day prior operation anemic patient ( day -3 ) . The treatment disclose patient health care worker treat patient operation . Patients without anemia iron deficiency also observe postoperative measurement perform . They serve natural comparison group . Treatment : Erythropoietin alpha ( Eprex , Janssen-Cilag AG , Baar ) 40'000 U sc . Ferric carboxymaltose ( Ferinject , Vifor ( International ) AG , St. Gallen ) 1000 mg 100 ml sodiumchloride ( NaCl ) 30 min . Vitamin B12 ( VitarubinÂ®-superconc. , Streuli Pharma AG , Uznach ) 1 mg sc . Folic acid ( Acidum folicum , Streuli Pharma AG , Uznach ) 5 mg po . The current transfusion coagulation guideline University Hospital Zurich follow group identically . Postoperatively regular ward Hb transfusion trigger 80 g/L apply</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>Inclusion criterion : Patients undergo valve and/or coronary bypass surgery Signed patient inform consent Only patient enrol wo n't emergency surgery day Exclusion criterion : Participation another clinical trial within last 4 week prior enrollment Addiction disease allow patient assess nature , scope possible consequence clinical tial Patients sign consent form may fully understand inadequate knowledge German . Patients reach age legal majority Pregnant lactate woman Jehovah 's Witnesses Patients endocarditis Existing allergy intolerance ferric carboxymaltose mannitol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Anemia</keyword>
	<keyword>Iron deficiency</keyword>
	<keyword>Cardiac surgery</keyword>
	<keyword>Perioperative Care</keyword>
</DOC>